JACELIN RICE: Open Payments
NPI 1124873427 · CHERRY HILL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,381 in 118 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $534 · 2025 $2,381
Food & beverage: $2,381
| Company | Payments | Amount |
|---|---|---|
| QOL Medical, LLC | 21 | $457 |
| Ardelyx, Inc. | 12 | $442 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 19 | $323 |
| ABBVIE INC. | 21 | $318 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $245 |
| Regeneron Healthcare Solutions, Inc. | 8 | $153 |
| Lilly USA, LLC | 6 | $114 |
| Celltrion USA Inc. | 6 | $109 |
| Janssen Biotech, Inc. | 1 | $100 |
| Phathom Pharmaceuticals, Inc. | 3 | $50 |
Products named: Sucraid, IBSRELA, XIFAXAN, CREON, ENTYVIO, DUPIXENT, VEGZELMA, TREMFYA.
Industry payments across NJ — which companies pay providers there.
